Source:http://linkedlifedata.com/resource/pubmed/id/11402027
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
32
|
| pubmed:dateCreated |
2001-8-6
|
| pubmed:abstractText |
Myc overexpression is a hallmark of human cancer and promotes transformation by facilitating immortalization. This function has been linked to the ability of c-Myc to induce the expression of the catalytic subunit of telomerase, telomerase reverse transcriptase (TERT), as ectopic expression of TERT immortalizes some primary human cell types. c-Myc up-regulates telomerase activity in primary mouse embryonic fibroblasts (MEFs) and myeloid cells. Paradoxically, Myc overexpression also triggers the ARF-p53 apoptotic program, which is activated when MEFs undergo replicative crises following culture ex vivo. The rare immortal variants that arise from these cultures generally suffer mutations in p53 or delete Ink4a/ARF, and Myc greatly increases the frequency of these events. Alternative reading frame (ARF)- and p53-null MEFs have increased telomerase activity, as do variant immortal clones that bypass replicative crisis. Similarly, immortal murine NIH-3T3 fibroblasts and myeloid 32D.3 and FDC-P1.2 cells do not express ARF and have robust telomerase activity. However, Myc overexpression in these immortal cells results in remarkably discordant regulation of TERT and telomerase activity. Furthermore, in MEFs and 32D.3 cells TERT expression and telomerase activity are regulated independently of endogenous c-Myc. Thus, the regulation of TERT and telomerase activity is complex and is also regulated by factors other than Myc, ARF, or p53.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0021-9258
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
10
|
| pubmed:volume |
276
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
29994-30001
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11402027-3T3 Cells,
pubmed-meshheading:11402027-Animals,
pubmed-meshheading:11402027-Apoptosis,
pubmed-meshheading:11402027-Blotting, Western,
pubmed-meshheading:11402027-Cell Line,
pubmed-meshheading:11402027-Cells, Cultured,
pubmed-meshheading:11402027-Down-Regulation,
pubmed-meshheading:11402027-Fibroblasts,
pubmed-meshheading:11402027-Humans,
pubmed-meshheading:11402027-Mice,
pubmed-meshheading:11402027-Mutation,
pubmed-meshheading:11402027-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:11402027-Reading Frames,
pubmed-meshheading:11402027-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:11402027-Telomerase,
pubmed-meshheading:11402027-Time Factors,
pubmed-meshheading:11402027-Transcription, Genetic,
pubmed-meshheading:11402027-Up-Regulation
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells.
|
| pubmed:affiliation |
Departments of Biochemistry and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|